The Epidermolysis bullosa Center Freiburg – patient care, diagnostics and research by Leena Bruckner-Tuderman & Daniela Kirstein
ORAL PRESENTATION Open Access
The Epidermolysis bullosa Center Freiburg –
patient care, diagnostics and research
Leena Bruckner-Tuderman*, Daniela Kirstein
From 7th European Conference on Rare Diseases and Orphan Products (ECRD 2014)
The Epidermolysis bullosa (EB) Center Freiburg is the
coordination center of the German EB-Network and a
national center of excellence for rare skin fragility dis-
orders. It combines clinical activities with internationally
competitive research and deals with molecular diagnostics,
clinical management, elucidation of disease mechanisms,
and development of evidence-based novel therapies
(Figure 1). EB is a group of severe and socially relevant
genetic skin diseases characterized by mechanically
induced blistering and life-long fragility of the skin. EB has
a highly negative personal, medical and socio-economic
impact on the life of the patients and their families, and
the unmet medical need is high. - The activities of the
EB-Network build upon the combination of clinical and
scientific expertise of the partners in Germany and
neighboring countries (cross-border care), and upon the
synergies generated in the past years.
The EB Center Freiburg performs molecular diagnostics,
coordinates multidisciplinary care for patients and their
families, advices general practitioners, medical specialists,
nursing staff and therapists, and disseminates information
to lay public and media. The office of the Center is avail-
able for enquiries for 24 hours and responds within
24 hours. The team includes a coordinator, physicians,
nurses, a social worker, a documentary clerk, scientists
and laboratory technicians with expertise in EB. The
consultations are usually out-patient or day clinic appoint-
ments, but hospital admission is possible for severe cases
requiring extensive medical treatments. Standardized
clinical practice with a diagnostic algorithm and standar-
dized patient documentation facilitates diagnostic
processes, and a weekly EB-expert meeting evaluates all
diagnoses as a quality assurance measure. Currently the
EB-patient registry contains data of >1000 patients with
molecular genetic diagnosis and has an associated bio-
material collection of skin biopsies, cells and blood
samples. These serve as basis for research on epidemiology
of EB and for clinical and laboratory investigations on
novel causes, disease mechanisms, genotype-phenotype
correlations and treatments for EB. - In addition to
numerous international research collaborations, the EB
Center is actively involved in larger structures for rare
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Figure 1 Panels from left to right – Building of the EB Center Freiburg; skin blister in EB; immunofluorescence staining of the skin; mutation
analysis
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diseases. The Freiburg Center for Rare Diseases [http://
www.uniklinik-freiburg.de/fzse.html] provides high-level
scientific expertise, innovative diagnostics and interdisci-
plinary care for people with rare disorders of the skin, the
musculoskeletal system, the kidney, the lung, the eye, the
blood and the immune systems. Internationally, EB-CliNet
[http://www.eb-clinet.org], a European network of EB
Centers, and the Genodermatoses Network, an interna-
tional network on rare skin diseases for professionals and
patients [http://www.genodermatoses-network.org] aim at
establishing a European Reference Network for genetic
skin diseases.
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